However, a previously published meta-analysis showed that the overexpression of LAG3 was correlated with a more favorable OS in several types of cancer, which could be attributed to the limited number of included studies and the enrollment of a large number of patients with early-stage cancer [80]. The gene discussed is LAG3; the disease is cancer.